Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Genetic Causes of Cardiac Disease / / edited by Jeanette Erdmann, Alessandra Moretti
| Genetic Causes of Cardiac Disease / / edited by Jeanette Erdmann, Alessandra Moretti |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (407 pages) : illustrations |
| Disciplina | 616.12042 |
| Collana | Cardiac and Vascular Biology |
| Soggetto topico |
Human physiology
Human genetics Cardiology Animal models in research Human Physiology Human Genetics Animal Models Malalties cardiovasculars |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-27371-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Genetics of adult and fetal forms of Long QT Syndrome -- The genetic landscape of cardiomyopathies. Genetic basis of mitochondrial cardiomyopathy -- The Genetics of Coronary Heart Disease -- Complex genetics and the etiology of human congenital heart disease-Familial Hypercholesterolemia -- Long non-codingRNAs in cardiovascular disease -- Mouse models to study inherited cardiomyopathy -- Interrogating cardiovascular genetics in zebrafish -- Human induced pluripotent stem cells as a platform for functional examination of cardiovascular genetics in a dish -- Systems medicine as a transforming tool for cardiovascular genetics -- Sex differences in prevalent cardiovascular disease in the general population. |
| Record Nr. | UNINA-9910373910303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Handbook of Cardiovascular Behavioral Medicine / / edited by Shari R. Waldstein, Willem J. Kop, Edward C. Suarez, William R. Lovallo, Leslie I. Katzel
| Handbook of Cardiovascular Behavioral Medicine / / edited by Shari R. Waldstein, Willem J. Kop, Edward C. Suarez, William R. Lovallo, Leslie I. Katzel |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (1559 pages) |
| Disciplina | 616.1071 |
| Soggetto topico |
Clinical health psychology
Internal medicine Public health Health Psychology Internal Medicine Public Health Sistema cardiovascular Malalties cardiovasculars Psicologia dels malalts |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 0-387-85960-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cardiovascular Behavioral Medicine: Past, Present, and Future -- Introduction to Cardiac Anatomy, Physiology, and Pathophysiology -- Classification of Cardiovascular Diseases: Epidemiology, Diagnosis and Treatment -- The Biopsychosocial Perspective on Cardiovascular Disease -- Childhood Factors in Adult Risk for Cardiovascular Disease -- Aging Changes in Cardiovascular Structure and Function -- Risk Factors for Ischemic Heart Disease in Women -- Stress and Heart Disease in Women: The Stockholm Women’s Intervention Trial in Coronary Heart Disease Study -- From Race to Racism in the Study of Cardiovascular Disease: Concepts and Measures -- Socioeconomic Status and Cardiovascular Disease -- Health Disparities and Cardiovascular Diseases -- Nicotine Dependence and Cardiovascular Diseases: Biobehavioral and Psychosocial Correlates -- Alcohol and the Cardiovascular System: Implications for Behavioral Medicine -- Impact of Specific Diets and Nutritional Supplements on Cardiovascular Diseases -- Understanding Obesity and Cardiometabolic Risk -- Physical Activity/Exercise and Cardiovascular Disease -- Sleep as a Biobehavioral Risk Factor for Cardiovascular Disease -- Methodological Challenges in the Measurement of Medication Adherence in Patients with Cardiovascular Disease -- Personality Factors in Cardiovascular Disease: The Big Five and Type D Personality -- Hostility and Health -- Negative Emotions: Depression, Exhaustion, Anxiety -- Positive Psychological Well-Being and Cardiovascular Disease -- Stress and the Development of Atherosclerotic Cardiovascular Disease -- Work and Cardiovascular Diseases -- Social Support and Cardiovascular Disease: Racism, Ethnic Discrimination, and Cardiovascular Health: Conceptual and Measurement Issues -- Religion, Spirituality and Cardiovascular Disease -- Aggregation of Psychosocial Risk Factors: Models and Methods -- Contexts and Cardiovascular Health -- Environmental Toxicants and Cardiovascular Behavioral Medicine -- Genetics in Cardiovascular Behavioral Medicine -- Hypertension -- The Measurement of Lipids and Lipoproteins in Behavioral Medicine Research -- Insulin, Glucose, and the Metabolic Syndrome in Cardiovascular Behavioral Medicine -- Inflammation, Atherosclerosis, and Psychological Factors -- Hemostasis and Endothelial Function -- Catecholamines and Catecholamine Receptors in Cardiovascular Behavioral Medicine -- The Assessment of Autonomic Influences on the Heart Using Impedance Cardiography and Heart Rate Variability -- Hypothalamic-Pituitary-Adrenocortical Axis -- Ambulatory Monitoring and Ecological Momentary Assessment -- Cardiovascular Reactivity and Risk for Cardiovascular Disease -- Neuroimaging and the Study of Cardiovascular Stress Reactivity -- Asymmetric Innervation of the Heart -- Biopsychosocial Factors in Coronary Artery Disease -- Chest Pain: Cardiac and Non -- Mental Stress-Induced Myocardial Ischemia: Prevalence, Clinical Significance and Treatment Implications -- Acute Behavioral and Psychosocial Triggers of Myocardial Infarction -- Cardiac Arrythmias and Sudden Cardiac Death -- Behavioral Medicine Treatments for Heart Failure -- Stroke and Carotid Artery Disease -- Congenital Heart Disease -- Coronary Artery Bypass Grafting: Psychosocial Dimensions of a Surgical Procedure -- Heart Transplantation -- Measuring Behavioral Outcomes in Cardiac Rehabilitation -- The Psychological Treatment of Cardiac Patients -- Quality of Life and Subjective Health: Strengthening the Subjective Perspective in Cardiology -- Cardiovascular Disease and Cognitive Function -- Diabetes and Cardiovascular Disease -- HIV-1 Spectrum Disease, Psychological Distress and Cardiometabolic Disease -- Measurement of Change -- Causal Modeling: Confounding, Mediation, Moderation, and some General Considerations in Regression Modeling -- Systematic Reviews and Meta-Analysis in Behavioral Medicine -- Ethical Issues in Cardiovascular Behavioral Medicine Research. |
| Record Nr. | UNINA-9910617305303321 |
| New York, NY : , : Springer New York : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Heart of the Matter : Key concepts in cardiovascular science / / edited by Cesare Terracciano, Samuel Guymer
| Heart of the Matter : Key concepts in cardiovascular science / / edited by Cesare Terracciano, Samuel Guymer |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XV, 236 p. 62 illus., 60 illus. in color.) |
| Disciplina | 611 |
| Collana | Learning Materials in Biosciences |
| Soggetto topico |
Molecular biology
Cardiovascular system Cardiology Developmental biology Molecular Medicine Cardiovascular Biology Developmental Biology Malalties cardiovasculars Sistema cardiovascular |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-24219-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Anatomy of the Heart and Coronary Vasculature -- Early Mechanisms of Cardiac Development -- Later Mechanisms of Cardiac Development -- Myocardial Microstructure and Contractile Apparatus -- An Introduction to the Cardiac Action Potentials -- Cardiac Excitation-Contraction Coupling -- Conduction in Normal and Diseased Myocardium -- Cell-Based Tachyarrhythmias and Bradyarrhythmias -- The Scientific Rationale of Artificial Pacing -- Cardiac Contractility -- The Scientific Basis of Heart Failure -- Molecular and Cellular Basis of Cardiomyopathies -- Substrate Remodelling Changes in Heart Failure -- Developments in Heart Failure: Mechanical Unloading with LVADs, Exosomes, and MicroRNAs -- Pharmacological Targets of Hypertension -- The Coagulation Cascade and its Therapeutic Modulation -- Cellular and Molecular Mechanisms of Atherosclerosis -- Molecular and Cellular Mechanisms of Angiogenesis -- Endothelial Function in Normal and Diseased Vessels. |
| Record Nr. | UNINA-9910373921503321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Imaging of inflammation and infection in cardiovascular diseases / / edited by Federico Caobelli
| Imaging of inflammation and infection in cardiovascular diseases / / edited by Federico Caobelli |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (274 pages) |
| Disciplina | 616.12075 |
| Soggetto topico |
Heart - Imaging
Heart - Infections Malalties cardiovasculars Malalties del cor Diagnòstic per la imatge Infeccions Inflamació |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-81131-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Part I: Challenges in Patient Preparation -- 1: Challenges in Patient Preparation -- 1.1 Introduction -- 1.2 Prolonged Intervals of Fasting -- 1.3 Dietary Modifications -- 1.4 Pharmacologic Approaches -- 1.5 Conclusion -- References -- Part II: Non-ischemic Diseases -- 2: Cardiac Sarcoidosis -- 2.1 Introduction -- 2.2 Screening for Cardiac Sarcoidosis -- 2.3 Diagnosis -- 2.4 Endomyocardial Biopsy: Imaging Guidance -- 2.5 CMR for Diagnosis/CMR Imaging Protocol -- 2.6 Late Gadolinium Enhancement (LGE) -- 2.7 Imaging Myocardial Inflammation and Quantitative Tissue Characterization with CMR T1 and T2 Mapping -- 2.8 Additional CMR Findings Suggestive of Cardiac Sarcoidosis -- 2.9 Differential Diagnosis -- 2.10 Treatment: Anti-Inflammatory Therapy -- 2.11 CMR for Arrhythmogenic Risk Stratification/ICD -- 2.12 Positron Emission Tomography -- 2.13 Positron Emission Tomography with Tracers Other than 18F-FDG -- 2.14 Prognosis -- 2.15 Follow-up and Monitoring of Anti-Inflammatory Response -- 2.16 Hybrid PET-CMR Imaging -- 2.17 Outlook -- 2.18 Conclusion -- References -- 3: Cardiac Amyloidosis -- 3.1 Introduction -- 3.1.1 Different Phenotypes of Cardiac Amyloidosis -- 3.1.1.1 AL Amyloidosis -- 3.1.1.2 ATTR Amyloidosis -- 3.1.2 Screening for Cardiac Amyloidosis -- 3.2 Diagnosis -- 3.2.1 Endomyocardial Biopsy -- 3.2.2 Cardiac Magnetic Resonance (CMR) Imaging -- 3.2.2.1 CMR Diagnosis and Imaging Protocol -- 3.2.2.2 Late Gadolinium Enhancement (LGE) -- 3.2.2.3 Quantitative Tissue Characterization with CMR Native T1, T2 and ECV Mapping -- 3.2.2.4 Differential Diagnosis of AL vs. ATTR Amyloid -- 3.2.3 Scintigraphy -- 3.2.3.1 Bone Avid Radiotracers -- Imaging Protocols and Interpretation -- Diagnostic Accuracy -- 3.2.3.2 Innervation Radiotracers -- 3.2.4 Positron Emission Tomography (PET).
3.2.5 Hybrid Imaging: PET/MRI -- 3.2.6 Diagnostic Algorithm for Diagnosis and Sub-Typing of Cardiac Amyloidosis -- 3.3 Treatment -- 3.4 Prognosis -- 3.5 Conclusion -- References -- Part III: Ischemic Diseases -- 4: Molecular Imaging of Vulnerable Plaque -- 4.1 Introduction -- 4.2 Biology and Pathogenesis of Atherosclerosis -- 4.2.1 History -- 4.2.2 Mechanisms of Atherosclerosis -- 4.2.2.1 Initiation of Atherosclerosis -- Vascular Endothelium and Atherosclerosis -- Hemodynamics Forces in Atherosclerosis -- Low-Density Lipoprotein Cholesterol -- Surface Adhesion Molecules -- Foam Cells Formation -- Progression of Atherosclerosis -- Smooth Muscle Cells and Atherosclerosis -- Calcification -- Plaque Neoangiogenesis -- Innate Immunity Cells in Atherosclerosis -- Adaptive Immunity in Atherosclerosis -- 4.2.3 Complication of Atherosclerosis -- 4.2.3.1 Inducible Ischemia -- 4.2.3.2 Plaque Rupture -- 4.2.3.3 Plaque Erosion -- 4.3 Metabolism of Glucose in Atherosclerosis -- 4.3.1 Glucose and Immune Cells -- 4.3.2 Imaging Inflammation in Atherosclerosis Using Glucose Metabolism -- 4.4 Targeting Chemokine Receptor Expression in Vulnerable Plaque -- 4.4.1 Technological Advancements: PET/MRI and Chemokine Receptor -- 4.4.2 Radiopharmaceutical Agents Advancements: Theragnostic and Chemochine Receptor -- 4.5 Targeting Microcalcification in Atherosclerosis -- 4.5.1 Atherosclerotic Plaque Calcium Deposition -- 4.5.2 Cardiovascular Risk Quantification -- 4.5.3 High/Risk Coronary Plaque Evaluation -- 4.5.4 Atherosclerotic Plaque Composition/Activity Assessment -- 4.6 Targeting Neovascularization in Atherosclerosis -- 4.7 Targeting SSRT-2 Receptor Expression in Atherosclerosis with DOTA-Derivatives-PET -- 4.8 Summary -- References -- 5: Post-Infarction Inflammatory Alterations -- 5.1 General Introduction. 5.2 Biology of Ventricular Remodeling -- 5.2.1 Pathobiology of Ventricular Remodeling Post-MI -- 5.2.2 The Inflammatory Response -- 5.2.2.1 Resident Inflammatory Cells -- Mast Cells -- Macrophages -- 5.2.2.2 Infiltrating Inflammatory Cells -- Polymorphonuclear Leukocytes -- Monocytes and Macrophages -- Dendritic Cells -- T and B Lymphocytes -- 5.2.2.3 Cardiomyocytes and ECM -- 5.2.3 Animal Models to Study Post-AMI Inflammation -- 5.2.3.1 Small Animal Models -- Open Chest -- Coronary Artery Ligation -- Topical Application of FeCl3 -- Closed Chest -- Isoproterenol Injection -- 5.2.3.2 Large Animal Models -- Open Chest -- Coronary Artery Ligation -- Gradual Constriction -- Hydraulic Occluder -- Topical Application of FeCl3 -- Closed Chest -- Balloon Inflation -- Embolization -- Endothelial Electrical Injury -- 5.3 The Role of Molecular Imaging -- 5.3.1 Cardiac MRI -- 5.3.2 Single-Photon Emission Computed Tomography -- 5.3.3 Positron Emission Tomography -- 5.4 Imaging Targets -- 5.4.1 Metabolic Activity -- 5.4.2 Labeled Cells -- 5.4.3 Membrane Receptors -- 5.4.4 Somatostatin Receptors -- 5.4.5 Mannose Receptor -- 5.4.6 Folate Receptor -- 5.4.7 Translocator Protein -- 5.4.8 Glucagon-like Peptide-1 Receptor (GLP-1R) -- 5.4.9 Chemokine Receptors -- 5.4.10 Lymphocyte Markers -- 5.4.10.1 Adhesion Molecules -- 5.4.10.2 Extracellular (Matrix) Components -- 5.5 Hybrid Imaging: The Added Value of Hybrid Imaging -- 5.6 Concluding Remarks -- References -- Part IV: Infection -- 6: Infection: Pericarditis -- 6.1 Pericardial Anatomy -- 6.2 Pericardial Pathologies -- 6.3 Aetiology and Pathophysiology -- 6.4 Clinical Manifestations and Diagnosis -- 6.5 Computed Tomography -- 6.6 Cardiovascular Magnetic Resonance (CMR) -- 6.6.1 Typical CMR Protocol for the Evaluation of Pericardial Disease -- 6.6.2 CMR and Acute Pericarditis. 6.6.3 CMR and Pericardial Effusions -- 6.6.4 CMR and Pericardial Constriction -- 6.6.5 Constrictive-Effusive Pericarditis -- 6.7 Molecular Imaging -- 6.8 Basics of Treatment -- 6.9 Conclusion -- References -- 7: Infection: Myocarditis -- 7.1 Introduction -- 7.2 Aetiology and Pathogenesis -- 7.3 From Acute Myocarditis to Chronic Inflammatory Cardiomyopathy and Heart Failure -- 7.4 Clinical Presentations and Diagnosis -- 7.5 Endomyocardial Biopsy -- 7.6 Cardiovascular Magnetic Resonance (CMR) -- 7.7 Infectious Inflammatory Cardiomyopathy -- 7.7.1 Idiopathic/Post-Viral Myocarditis -- 7.8 Coronavirus Disease-2019 (COVID-19) and Myocarditis -- 7.9 Non-Infectious Inflammatory Cardiomyopathy -- 7.9.1 Connective Tissue Disease -- 7.9.1.1 Systemic Lupus Erythematosus -- 7.9.1.2 Rheumatoid Arthritis -- 7.9.1.3 Systemic Sclerosis/Systemic Scleroderma -- 7.9.1.4 Behçet's Disease -- 7.9.1.5 Polyarteritis Nodosa -- 7.10 Eosinophilic Myocarditis/Endomyocardial fibrosis -- 7.10.1 EGPA -- 7.10.2 Infectious Endomyocarditis and Endomyocardial Fibrosis -- 7.10.3 Haematological -- 7.11 Drug-Induced or Toxic Myocarditis -- 7.12 Inflammatory Myositis -- 7.13 Giant Cell Myocarditis -- 7.14 Genetic Causes -- 7.15 Molecular Imaging -- 7.16 Hybrid Imaging -- 7.17 Summary -- References -- 8: Cardiac Devices Infection -- 8.1 Introduction -- 8.2 Scintigraphy in Cardiac Devices Infection -- 8.2.1 Radiolabelling of White Blood Cells with 99mTc-HMPAO or 111In-oxine -- 8.2.2 Image Acquisition -- 8.2.3 Image Interpretation -- 8.2.4 Radiolabelled WBC Scintigraphy of CIED Infection -- 8.2.5 Radiolabelled WBC Imaging of Left Ventricular Assist Devices Infection -- 8.2.6 Merits and Limitations of Radiolabelled WBC Scintigraphy in Cardiac Devices Infection: Alternative SPECT Tracers -- 8.3 FDG PET/CT Imaging of Cardiac Devices Infection. 8.3.1 Patient Preparation -- 8.3.1.1 Suppression of Myocardial FDG Uptake -- 8.3.1.2 Withdrawal of Medications -- 8.3.2 Image Acquisition and Interpretation -- 8.3.3 FDG PET/CT Imaging of CIED Infection -- 8.3.4 FDG PET/CT Imaging of LVAD Infection -- 8.3.5 FDG PET/CT for Extra-Cardiac Disease in Patients Assessed for Cardiac Devices Infection -- 8.4 Comparative Performance of Radionuclide WBC Scintigraphy and FDG PET/CT in Cardiac Devices Infection -- 8.5 Conclusion -- References -- 9: Endocarditis -- 9.1 Introduction -- 9.2 Single Photon Emission Tomography (SPECT) -- 9.2.1 67Ga-citrate Scintigraphy -- 9.2.2 Labelled Leukocytes Scintigraphy -- 9.2.3 Other SPECT Tracers -- 9.3 Positron Emission Tomography (PET) -- 9.4 Concluding Remarks -- References. |
| Record Nr. | UNINA-9910502664303321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Journal of cardiovascular and thoracic research
| Journal of cardiovascular and thoracic research |
| Pubbl/distr/stampa | Tabriz : , : Cardiovascular Research Center of Tabriz University of Medical Sciences, , 2009- |
| Soggetto topico |
Cardiovascular system
Cardiovascular system - Diseases Chest - Diseases Cardiovascular Diseases Thoracic Diseases Sistema cardiovascular Malalties cardiovasculars |
| Soggetto genere / forma |
Periodical
Periodicals. Revistes electròniques. |
| ISSN | 2008-6830 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
J. cardiovasc. thorac. res
JCVTR |
| Record Nr. | UNISA-996321609903316 |
| Tabriz : , : Cardiovascular Research Center of Tabriz University of Medical Sciences, , 2009- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Journal of cardiovascular and thoracic research
| Journal of cardiovascular and thoracic research |
| Pubbl/distr/stampa | Tabriz : , : Cardiovascular Research Center of Tabriz University of Medical Sciences, , 2009- |
| Soggetto topico |
Cardiovascular system
Cardiovascular system - Diseases Chest - Diseases Cardiovascular Diseases Thoracic Diseases Sistema cardiovascular Malalties cardiovasculars |
| Soggetto genere / forma |
Periodical
Periodicals. Revistes electròniques. |
| ISSN | 2008-6830 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
J. cardiovasc. thorac. res
JCVTR |
| Record Nr. | UNINA-9910141109603321 |
| Tabriz : , : Cardiovascular Research Center of Tabriz University of Medical Sciences, , 2009- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease / / edited by Xian-Cheng Jiang
| Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease / / edited by Xian-Cheng Jiang |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (VIII, 234 p. 38 illus., 27 illus. in color.) |
| Disciplina | 634.905 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Human physiology
Lipids Cardiovascular system Human Physiology Lipidology Cardiovascular Biology Lípids Malalties cardiovasculars |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-6082-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases -- Chapter 2: Cholesteryl Ester Transfer Protein and Lipid Metabolism and Cardiovascular Diseases -- Chapter 3: Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein in Lipid Metabolism and Cardiovascular Diseases -- Chapter 4: Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases -- Chapter 5: Circadian-Clock Regulation on Lipid Metabolism and Metabolic Diseases -- Chapter 6: ABC Transporters, Cholesterol Efflux and Implications for Cardiovascular Diseases -- Chapter 7: Apolipoprotein M: research progress and clinical perspective -- Chapter 8: Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease -- Chapter 9: Proprotein Convertase Subtilisin/Kexin-type 9 and Lipid Metabolism -- Chapter 10: LDL and HDL Oxidative Modification and Atherosclerosis -- Chapter 11: Rare Diseases Related with Lipoprotein Metabolism -- Chapter 12: Preβ1 High Density Lipoprotein in Cardiovascular Diseases -- Chapter 13: CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis -- Chapter 14: Mfsd2a, a physiologically important lysolipid transporter in brain and eye. |
| Record Nr. | UNINA-9910416105603321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer / / Paul Holvoet
| Non-coding RNAs at the cross-road of cardiometabolic diseases and cancer / / Paul Holvoet |
| Autore | Holvoet Paul |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (xxx, 265 pages) : illustrations |
| Disciplina | 572.88 |
| Soggetto topico |
Non-coding RNA
Cardiovascular system - Diseases - Molecular aspects Metabolism - Disorders - Molecular aspects Cancer - Genetic aspects Càncer Malalties cardiovasculars Trastorns del metabolisme Genètica molecular humana |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-68844-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgments -- Introduction -- The Move Towards Cellular Risk Markers -- Why Non-coding RNA? -- Objectives -- Approach -- Take Home Message -- References -- Contents -- Abbreviations -- 1 Biogenesis and Modes of Action of miRs and Circular and Long Non-coding RNAs -- 1.1 MiRs -- 1.1.1 Biogenesis of miRs -- 1.1.2 MiR Modes of Action -- 1.1.3 Naming of miRs -- 1.1.4 Useful Resources on miRs -- 1.2 Circular RNAs -- 1.2.1 Biogenesis of Circular RNAs -- 1.2.2 Circular RNAs Modes of Action -- 1.2.3 Useful Resources on Circ-RNAs -- 1.3 lncRNAs -- 1.3.1 Biogenesis of lncRNAs -- 1.3.2 Modes of Action of lncRNAs -- 1.4 piRs -- 1.4.1 Biogenesis of piRs -- 1.4.2 Modes of Action of piRs -- 1.4.3 Useful Resources on piRs -- References -- 2 Non-coding RNAs Related to Obesity -- 2.1 Mechanisms in White Adipogenesis -- 2.1.1 Role of Non-coding RNAs in White Adipogenesis -- 2.2 Inflammation and Insulin Resistance in Obese White Adipose Tissue -- 2.2.1 Role of Non-coding RNAs in Inflammation and Insulin Resistance in Obese White Adipose Tissue -- 2.3 Mechanisms in Brown Adipogenesis and Thermogenesis -- 2.3.1 Role of Non-coding RNAs in Brown Adipogenesis and Thermogenesis -- 2.4 Mechanisms in Browning of White Adipose Tissues -- 2.4.1 Role of Non-coding RNAs in Browning of White Adipose Tissue -- 2.5 Leptin and Insulin in the Hypothalamus -- 2.5.1 Non-coding RNAs Related to Leptin and Insulin in the Hypothalamus -- References -- 3 Non-coding RNAS Related to Type 2 Diabetes -- 3.1 Mechanisms in β Cell Maturation -- 3.1.1 Non-coding RNAs Related to β Cell Maturation -- 3.2 Mechanisms in Insulin Signaling in the Pancreas -- 3.2.1 Non-coding RNAs in Insulin Signaling in Type 2 Diabetes -- 3.3 Inflammation in the Pancreas, Insulin Resistance, and Type 2 Diabetes.
3.3.1 Non-coding RNAs Related to Inflammation in the Pancreas, with Insulin Resistance and Type 2 Diabetes -- References -- 4 Non-coding RNAs Related to Lipid Metabolism and Non-alcoholic Fatty Liver Disease -- 4.1 Cholesterol and Lipids in the Liver -- 4.1.1 Non-coding RNAs and Cholesterol in the Liver -- 4.2 Fatty Acids and Triglycerides -- 4.2.1 Non-coding RNAs and Fatty Acids and Triglycerides -- 4.3 Non-alcoholic Fatty Liver Disease -- 4.3.1 Non-coding RNAs Related to Non-alcoholic Fatty Liver Disease -- References -- 5 Non-coding RNAs Related to Atherosclerosis -- 5.1 Endothelial Injury, Inflammation, and Apoptosis -- 5.1.1 Non-coding RNAs in Endothelial Injury, Inflammation, and Apoptosis -- 5.2 Fibroproliferative Remodeling and Plaque Destabilization -- 5.2.1 Non-coding RNAs in Fibroproliferative Remodeling and Plaque Destabilization -- References -- 6 Non-coding RNAs in Cardiomyopathy and Heart Failure -- 6.1 Mechanisms in Cardiomyopathy and Heart Failure -- 6.2 Non-coding RNAs in Cardiomyopathy and Heart Failure -- 6.2.1 Non-coding RNAs in Cardiac Hypertrophy -- 6.2.2 Non-coding RNAs in Cardiac Fibrosis and ECM Deposition -- 6.2.3 Non-coding RNAs in Cardiac Inflammation -- 6.2.4 Non-coding RNAs in Cardiac Angiogenesis -- 6.2.5 Non-coding RNAs in Cardiac Apoptosis -- 6.3 Metabolic Syndrome: The Link Between Metabolic and Cardiovascular Diseases -- 6.3.1 Definition of Metabolic Syndrome -- 6.3.2 Oxidative Stress and Metabolic Syndrome -- 6.3.3 Metabolic Syndrome and Cardiovascular Risk -- 6.3.4 Non-coding RNAs and Metabolic Syndrome Components -- References -- 7 Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer -- 7.1 Mechanisms of Cancer Progression -- 7.1.1 Induction of Stemness -- 7.1.2 Induction of EMT -- 7.1.3 Induction of Insulin Sensitized State, Cancer Cell Proliferation, and Protection Against Apoptosis. 7.1.4 Induction of Glycolysis -- 7.1.5 Induction of Angiogenesis -- 7.1.6 Repression of Anti-tumor Immunity and Apoptosis -- 7.1.7 Cancer Cell Proliferation -- 7.1.8 EGFR Signaling and Cancer Progression -- 7.1.9 BMI1 and EZH2 in Cancer Progression -- 7.2 Non-coding RNAs Related to Metabolic and Cardiovascular Diseases Are also Involved in Cancer Progression -- 7.3 Comparison of the Role of Non-coding RNAs in Cardiometabolic Diseases and Cancer -- References -- 8 Regulation of Non-coding RNAs in Cardiometabolic Tissues and Tumors -- 8.1 Regulation of miRs -- 8.1.1 Hypoxia -- 8.1.2 Glucose -- 8.1.3 Oxidative Stress -- 8.1.4 Inflammation -- 8.1.5 TGF-β -- 8.1.6 MYC -- 8.1.7 Overview -- 8.2 Differences in miR-Profiles in Cardiometabolic Tissues and Tumors May be Due to the Typical Action of lncRNAs and circ-RNAs in Tumors -- 8.3 Action of piRs Particularly in Tumors -- References -- 9 Communication Between Tumor-Adjacent Tissues and Tumors with Emphasis on Role of Inflammatory Cells -- 9.1 Exchange of miR-Enriched Microvesicles -- 9.2 MiR-155 as a Link Between M1 Macrophage-Mediated Inflammation in Tumor-Adjacent Tissue and Tumor Growth and Metastasis -- References -- 10 The Impact of Non-coding RNA Networks on Disease Comorbidity: Cardiometabolic Diseases, Inflammatory Diseases, and Cancer -- 10.1 Identification of Non-coding RNAs at Cross-Road of Metabolic and Cardiovascular Diseases -- 10.2 Many Non-coding RNAs at Cross-Road of Metabolic and Cardiovascular Diseases are also Related to Inflammatory Diseases -- 10.3 Differences Between Non-coding RNAs in Cardiometabolic Tissues and Tumors -- 10.4 Expected Technical Developments Underlying the Use of Non-coding RNAs as Biomarkers -- 10.5 The Need for Measuring Fluctuation of Non-coding RNAs -- References. |
| Record Nr. | UNINA-9910483036503321 |
Holvoet Paul
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-coding RNAs in Cardiovascular Diseases / / edited by Junjie Xiao
| Non-coding RNAs in Cardiovascular Diseases / / edited by Junjie Xiao |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (VII, 426 p. 27 illus., 23 illus. in color.) |
| Disciplina | 612.1 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Molecular biology
Human genetics Cardiology Molecular Medicine Human Genetics Malalties cardiovasculars RNA |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-1671-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I Overview -- 1. An overview of non-coding RNAs and cardiovascular system -- Section II Bioinformatics and Interactions -- 2. Bioinformatics research methodology of non-coding RNAs in cardiovascular diseases -- 3. Online databases and non-coding RNAs in cardiovascular diseases -- 4. Interactions among non-coding RNAs involved in regulating of cardiovascular diseases -- 5. RNA-binding proteins (RBPs) and non-coding RNAs in cardiovascular diseases -- Section III Non-coding RNAs regulation in cardiovascular system -- 6. Involvement of epigenetic control and non-coding RNAs in cardiovascular system -- 7. Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseases -- 8. Non-coding RNAs and physiological cardiac hypertrophy -- 9. Non-coding RNAs and cardiac regeneration -- 10. Role of non-coding RNA in diabetic cardiomyopathy -- 11. Comprehensive overview of non-coding RNAs in cardiac development -- Section IV Non-coding RNAs and Cardiovascular diseases -- 12. Non-coding RNAs and heart failure -- 13. Non-coding RNAs and pathological cardiac hypertrophy -- 14. Non-coding RNAs and cardiac aging -- 15. Non-coding RNAs and ischemic cardiovascular diseases -- 16. Non-coding RNAs and coronary artery disease -- 17. Non-coding RNAs and cardiac arrhythmias -- 18. Non-coding RNA and cardiac electrophysiological disorders -- 19. Non-coding RNAs and atrial fibrillation -- 20. Y RNAs: Biogenesis, Function and Implications for the Cardiovascular System -- 21. Translational potential of non-coding RNAs for cardiovascular disease -- Section V Potential biomarkers and Therapeutic implications -- 22. Circulating non-coding RNAs and Cardiovascular Diseases -- 23. Small interfering RNAs and RNA therapeutics in Cardiovascular Diseases -- Section VI Future Prospects -- 24. Prospective advances in non-coding RNAs investigation. |
| Record Nr. | UNINA-9910409698703321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nursing the cardiac patient [[electronic resource]]
| Nursing the cardiac patient [[electronic resource]] |
| Autore | Humphreys Melanie |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina |
616.1/20231
616.120231 |
| Collana | Essential Clinical Skills for Nurses |
| Soggetto topico |
Heart - Diseases - Nursing - Great Britain
Heart - Patients - Nursing - Diseases - Great Britain Cardiovascular Diseases - nursing Nursing Care - methods Infermeria cardiovascular Malalties cardiovasculars |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
1-118-78533-9
1-283-24056-4 1-78034-581-X 9786613240569 1-4443-4612-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Nursing the Cardiac Patient; Contents; Contributor Biographies; Preface; Acknowledgements; Chapter 1: Acute Coronary Syndrome in Perspective; Introduction; The challenge of saving lives; The scope of this book; Chapter 2: Reducing the Risk: Primary Care Initiatives; Introduction; Primary care initiatives in perspective; Identification of those "at risk"; Rapid access chest pain clinics; Sudden cardiac death; Early recognition and access to emergency services; Early CPR; Early defibrillation; First responders; Summary; Chapter 3: Assessment of the Cardiovascular System; Introduction
Cardiovascular assessment in perspectiveChest pain assessment; Electrocardiography; Laboratory tests; Diagnostic procedures; Summary; Chapter 4: Diagnosing Acute Coronary Syndrome; Introduction; Acute coronary syndromes in perspective; Interpreting the 12-lead ECG; Biochemical markers; Risk stratification; Imaging techniques; Summary; Chapter 5: Unstable Angina; Introduction; Unstable angina in perspective; Treatment strategies; Summary; Chapter 6: Non-ST Segment Elevation Myocardial Infarction; Introduction; Non-ST segment elevation myocardial infarction in perspective; Causes; Diagnosis Treatment of NSTEMISummary; Chapter 7: ST Segment Elevation Myocardial Infarction; Introduction; ST segment elevation myocardial infarction in perspective; Care priorities; Treatment priorities; Complications of STEMI; Territories of STEMI : special considerations; Special patient groups; Continuing care; Rehabilitation and secondary prevention; Summary; Chapter 8: Therapeutic Intervention in Acute Coronary Syndromes; Introduction; Pathophysiology of ACS; Early identification of ACS; Early therapeutic intervention; Therapeutic intervention for STE-ACS and NSTE-ACS Primary percutaneous coronary interventionFacilitated percutaneous coronary intervention; Summary; Chapter 9: Cardiothoracic Care; Introduction; Preparation for surgery; The operation; Postoperative care; Cardiac care after the first 24 hours; Fast tracking; Discharge; Summary; Chapter 10: Arrhythmias and their Management; Introduction; Electrophysiology of the heart; The conduction system; Manifestations of arrhythmias; Arrhythmias; Arrhythmia treatment; Peri-arrest arrhythmias; Cardiac arrest rhythms; Summary; Chapter 11: Emergency Cardiac Care; Introduction Cardiac emergencies in perspectiveEarly warning scoring systems; Assessing the emergency cardiac patient; Acute heart failure; Pericarditis; Cardiac tamponade; Electrolyte disorders; Summary; Chapter 12: Long-Term Cardiac Conditions; Introduction; Heart failure; Refractory angina; Atrial fibrillation; Summary; Chapter 13: Cardiac Rehabilitation; Introduction; Cardiac rehabilitation in perspective; Provision of cardiac rehabilitation; Summary; Chapter 14: Secondary Prevention Within the Community; Introduction; Ongoing risk factor modification; Psychological wellbeing; Psychosocial wellbeing Cardioprotective medication |
| Record Nr. | UNINA-9910139555403321 |
|
Humphreys Melanie
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
